RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 95 filers reported holding RA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $409,000 | -41.6% | 8,522 | -42.9% | 0.00% | 0.0% |
| Q4 2019 | $700,000 | +77.2% | 14,913 | -10.7% | 0.00% | +50.0% |
| Q3 2019 | $395,000 | -8.4% | 16,692 | +16.4% | 0.00% | -33.3% |
| Q2 2019 | $431,000 | +17.8% | 14,340 | -12.2% | 0.00% | +50.0% |
| Q1 2019 | $366,000 | +60.5% | 16,328 | +30.4% | 0.00% | 0.0% |
| Q4 2018 | $228,000 | -15.9% | 12,518 | -16.3% | 0.00% | 0.0% |
| Q3 2018 | $271,000 | +76.0% | 14,956 | -3.3% | 0.00% | +100.0% |
| Q2 2018 | $154,000 | +77.0% | 15,472 | -5.7% | 0.00% | 0.0% |
| Q1 2018 | $87,000 | -26.3% | 16,410 | +17.8% | 0.00% | 0.0% |
| Q4 2017 | $118,000 | – | 13,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|